Tech Base/Enabling Rsrch for Infect Dis Adv Tech
Abstract
Technology development, demonstration, and transition of Food and Drug Administration (FDA) - regulated medical countermeasures such as drugs and vaccines to naturally-occurring infectious diseases of military importance, as identified by worldwide medical surveillance and capability needs assessments. Research is conducted in compliance with FDA regulations for medical products for human use. Work is managed by the United States Army Medical Research and Development Command (USAMRDC) in coordination with the Naval Medical Research Center (NMRC). The Army is responsible for programming and funding all Department of Defense (DoD) naturally occurring infectious disease research requirements, thereby precluding duplication of effort within the Military Departments. Promising medical countermeasures identified in this Project are further matured under PE 0603807A (Medical Systems Advanced Development) Project 808 (DoD Drug & Vacc Ad). The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. All FY20 adjustments align program resources to Army Modernization Priorities in support of the National Defense Strategy. Work in this Project is performed by the USAMRDC, Fort Detrick, MD. Efforts in this Project support the Soldier portfolio and the principal area of Military Relevant Infectious Diseases.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2021
- Source ID
- MM9_0603002A_3_2040_PB_2021
Related Documents
- Root: Medical Advanced Technology
- Child Accomplishment: Advanced Technology Research on drugs and vaccines against parasitic diseases
- Child Accomplishment: Viral Disease Threats
- Child Accomplishment: FY 2020 SBIR/STTR Transfer